In response to Drs. Dubben, Beck-Bornholdt, and Llogie

Int J Radiat Oncol Biol Phys. 2002 Mar 15;52(4):1148-50. doi: 10.1016/s0360-3016(01)02777-8.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Clinical Trials, Phase III as Topic
  • Combined Modality Therapy
  • Dose Fractionation, Radiation*
  • Head and Neck Neoplasms / radiotherapy*
  • Humans
  • Radiation Injuries / etiology*
  • Radiotherapy / adverse effects
  • Randomized Controlled Trials as Topic
  • Time Factors
  • Treatment Outcome

Substances

  • Antineoplastic Agents